114 related articles for article (PubMed ID: 3044277)
21. Carboplatin, an active drug in advanced head and neck cancer.
de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
[TBL] [Abstract][Full Text] [Related]
22. [Nedaplatin].
Ota K
Gan To Kagaku Ryoho; 1996 Feb; 23(3):379-87. PubMed ID: 8712835
[TBL] [Abstract][Full Text] [Related]
23. Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.
Sternberg C; Kelsen D; Dukeman M; Leichman L; Heelan R
Cancer Treat Rep; 1985 Nov; 69(11):1305-7. PubMed ID: 3912041
[TBL] [Abstract][Full Text] [Related]
24. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
Curt GA; Grygiel JJ; Corden BJ; Ozols RF; Weiss RB; Tell DT; Myers CE; Collins JM
Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
[TBL] [Abstract][Full Text] [Related]
25. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
Taguchi T; Wakui A; Nabeya K; Kurihara M; Isono K; Kakegawa T; Ota K
Gan To Kagaku Ryoho; 1992 Apr; 19(4):483-8. PubMed ID: 1558398
[TBL] [Abstract][Full Text] [Related]
26. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
Langer CJ; Millenson M; O'Dwyer P; Kosierowski R; Alexander R; Litwin S; McAleer CA; Bonjo CA; Ozols R
Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of carboplatin in advanced malignant melanoma.
Evans LM; Casper ES; Rosenbluth R
Cancer Treat Rep; 1987 Feb; 71(2):171-2. PubMed ID: 3542209
[TBL] [Abstract][Full Text] [Related]
28. Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.
Van Echo DA; Egorin MJ; Whitacre MY; Olman EA; Aisner J
Cancer Treat Rep; 1984 Sep; 68(9):1103-14. PubMed ID: 6383605
[TBL] [Abstract][Full Text] [Related]
29. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J
Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128
[TBL] [Abstract][Full Text] [Related]
30. Pediatric phase I trial of carboplatin: a Childrens Cancer Study Group report.
Gaynon PS; Ettinger LJ; Moel D; Siegel SE; Baum ES; Krivit W; Hammond GD
Cancer Treat Rep; 1987 Nov; 71(11):1039-42. PubMed ID: 3315195
[TBL] [Abstract][Full Text] [Related]
31. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
[No Abstract] [Full Text] [Related]
32. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study.
Tsavaris N; Kosmas C; Skopelitis H; Dimitrakopoulos A; Kopterides P; Bougas D; Stravodimos K; Mitropoulos D; Alamanis C; Giannopoulos A
J Chemother; 2005 Aug; 17(4):441-8. PubMed ID: 16167525
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
[TBL] [Abstract][Full Text] [Related]
35. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group.
Akaza H; Togashi M; Nishio Y; Miki T; Kotake T; Matsumura Y; Yoshida O; Aso Y
Cancer Chemother Pharmacol; 1992; 31(3):187-92. PubMed ID: 1334448
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
[TBL] [Abstract][Full Text] [Related]
38. Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study.
Al-Sarraf M; Metch B; Kish J; Ensley J; Rinehart JJ; Schuller DE; Coltman CA
Cancer Treat Rep; 1987; 71(7-8):723-6. PubMed ID: 3300967
[TBL] [Abstract][Full Text] [Related]
39. [Chemotherapy of advanced genitourinary carcinoma with cis-diamminedichloroplatinum].
Uchida T; Kobayashi K; Arakawa T; Omata T; Li K; Ikeda S; Endo T; Ishibashi A; Koshiba K
Hinyokika Kiyo; 1984 Sep; 30(9):1173-83. PubMed ID: 6084421
[TBL] [Abstract][Full Text] [Related]
40. [A phase II study of DWA2114R, a new platinum complex for breast cancer].
Aoyama H; Kubo K; Uchino J; Hayasaka H; Asaishi K; Izuo M; Ogawa M; Majima H; Yasutomi M; Wada T
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1033-9. PubMed ID: 1626939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]